🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 19 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 12/07/2002 | 27,17 | 28,22 | 25,83 | 26,31 | -1,54% | 8,82% | 160.247 |
| 11/07/2002 | 25,15 | 27,47 | 24,89 | 26,72 | +5,31% | 10,27% | 554.050 |
| 10/07/2002 | 26,65 | 26,69 | 23,54 | 25,38 | -28,93% | 11,80% | 1.816.466 |
| 09/07/2002 | 38,93 | 39,45 | 34,92 | 35,71 | -8,71% | 11,63% | 401.605 |
| 08/07/2002 | 38,22 | 41,32 | 38,18 | 39,11 | +2,15% | 8,23% | 166.285 |
| 05/07/2002 | 37,43 | 38,70 | 37,36 | 38,29 | +1,79% | 3,60% | 175.448 |
| 03/07/2002 | 41,58 | 41,58 | 35,90 | 37,62 | -9,46% | 13,68% | 698.668 |
| 02/07/2002 | 48,47 | 48,62 | 41,17 | 41,55 | -16,10% | 15,37% | 495.327 |
| 01/07/2002 | 54,27 | 55,10 | 47,39 | 49,52 | -8,76% | 14,21% | 180.952 |
| 28/06/2002 | 55,10 | 60,41 | 53,90 | 54,27 | -1,36% | 11,82% | 418.089 |
| 27/06/2002 | 51,09 | 55,02 | 50,72 | 55,02 | +8,49% | 8,42% | 154.315 |
| 26/06/2002 | 50,27 | 52,33 | 48,17 | 50,72 | -2,02% | 8,27% | 93.348 |
| 25/06/2002 | 51,47 | 52,40 | 50,94 | 51,77 | +1,77% | 2,84% | 137.350 |
| 24/06/2002 | 51,28 | 51,84 | 48,66 | 50,87 | -2,72% | 6,20% | 149.079 |
| 21/06/2002 | 52,29 | 53,11 | 51,50 | 52,29 | +3,02% | 3,08% | 78.600 |
| 20/06/2002 | 51,09 | 52,21 | 50,34 | 50,75 | -1,31% | 3,66% | 69.570 |
| 19/06/2002 | 53,64 | 53,64 | 51,39 | 51,43 | -3,44% | 4,19% | 84.211 |
| 18/06/2002 | 52,29 | 53,75 | 52,29 | 53,26 | +1,21% | 2,79% | 138.259 |
| 17/06/2002 | 53,41 | 54,98 | 51,77 | 52,63 | -2,90% | 6,03% | 143.175 |
| 14/06/2002 | 49,78 | 54,27 | 48,85 | 54,20 | +7,90% | 10,90% | 76.143 |
| 13/06/2002 | 50,53 | 52,21 | 49,86 | 50,23 | -0,52% | 4,67% | 68.956 |
| 12/06/2002 | 48,66 | 50,94 | 47,24 | 50,49 | +2,82% | 7,62% | 140.850 |
| 11/06/2002 | 52,40 | 53,45 | 48,17 | 49,11 | -6,35% | 10,07% | 323.058 |
| 10/06/2002 | 48,02 | 53,82 | 47,76 | 52,44 | +8,94% | 12,63% | 257.308 |
| 07/06/2002 | 50,98 | 51,02 | 43,79 | 48,13 | -12,34% | 14,17% | 734.441 |
| 06/06/2002 | 62,66 | 62,73 | 54,65 | 54,91 | -12,37% | 12,90% | 274.220 |
| 05/06/2002 | 61,76 | 62,69 | 60,94 | 62,66 | +1,52% | 2,85% | 137.163 |
| 04/06/2002 | 61,95 | 62,25 | 59,25 | 61,72 | -0,90% | 4,83% | 91.798 |
| 03/06/2002 | 67,22 | 67,37 | 61,20 | 62,28 | -8,37% | 9,19% | 137.057 |
| 31/05/2002 | 67,26 | 68,08 | 66,06 | 67,97 | +0,83% | 3,00% | 139.461 |